Modulating SIRT6 activity by its pharmacological activation using specific drugs may, therefore, offer an attractive, non-invasive strategy to ameliorate age-dependent disc degeneration and to preserve disc health in the aging spine. The gene discussed is SIRT6; the disease is age.